Viatris Inc recalls Levothyroxine Sodium Tablets USP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Superpotent Drug and Subpotent Drug: potency failures obtained
- Products
-
- Levothyroxine Sodium Tablets USP
- Company
- Viatris Inc
- Where it was sold
-
Nationwide within the United States and Puerto Rico
Nationwide
- Units affected
- 19, 549 bottles
- About this recall
- Levothyroxine Sodium Tablets USP, 175 mcg, packaged in a) 90-count bottles (NDC 0378-1817-77) and b) 1000-count bottles (NDC 0378-1817-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.